| Listed ingredient / strength | Listed as esketamine (R-ketamine); |
|---|---|
| Usage | Managing acute and chronic pain, and, more recently, treating treatment-resistant mental health conditions. • Methods: Typically sold as a white powder or liquid. It is most commonly snorted, swallowed in pill/capsule form, or occasionally injected. • Context: Used for its visual distortions, feelings of detachment, and euphoric effects. |
| ⚠️ Effects | Desired / Mind-Altering Effects • Dissociation: A feeling of detachment from one’s physical body, surroundings, or reality. • Euphorics & Mood Shifts: Feelings of lightness, calmness, or floating. • Perceptual Changes: Mild visual or auditory hallucinations, distorted sense of time, space, and body image. • Pain Relief: Significant numbing of physical pain. Physical & Cognitive Effects • Numbness, loss of motor coordination, and slurred speech. • Elevated heart rate and blood pressure. • Nausea or vomiting. • Involuntary, rapid eye movements (nystagmus). |
| Texture | Sold as liquid |
| Canadian regulatory status | Ketamine is controlled under Schedule I. Authorized ketamine products are prescription injections; authorized esketamine nasal treatment has specific clinical controls. This product is not verified as an authorized formulation. |
Established Medical Uses
Ketamine injection is an authorized general anaesthetic used by trained professionals. Some ketamine use for mental illness is off-label, and Health Canada notes that its risks and benefits for off-label conditions and formulations have not been assessed. An unverified spray or powder is not equivalent to supervised treatment.
Authoritative sources:Health Canada — Health Product InfoWatch: ketamine safety information
Health Canada Drug Product Database — Ketamine hydrochloride injection product monograph
Department of Justice Canada — Controlled Drugs and Substances Act.
Product-specific identity and label claims remain unverified unless stated otherwise.


Reviews
There are no reviews yet.